Smith Jeffrey T L
SEC insider (Form 3/4/5 filer). CIK 0001604800. EVP & Chief Medical Officer at Zymeworks Inc. (ZYME). 8 reported Form 4/5 transactions since Sep 2024; latest on Jan 12, 2026. Located in MIDDLETOWN, DE.
Companies Smith Jeffrey T L has filed insider reports for
- Zymeworks Inc. (ZYME): Officer, EVP & Chief Medical Officer
Smith Jeffrey T L
CIK: 0001604800
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (37.5%)
Position reduction
Option Exercises (M)3 (37.5%)
Derivative conversions
Awards (A)2 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ZYME
Zymeworks Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jan 12, 2026ZYME
Zymeworks Inc.
ExerciseDirect17.7K shares- - Jan 12, 2026ZYME
Zymeworks Inc.
SaleDirect9.3K shares at avg. $22.67$211K - Jan 5, 2026ZYME
Zymeworks Inc.
ExerciseDirect20K shares- - Jan 5, 2026ZYME
Zymeworks Inc.
SaleDirect10.5K shares at avg. $25.10$264K - Jan 10, 2025ZYME
Zymeworks Inc.
AwardDirectRestricted Stock Unit
53K shares- - Jan 10, 2025ZYME
Zymeworks Inc.
AwardDirectStock Option (Right to Buy)
79K shares- - Jan 6, 2025ZYME
Zymeworks Inc.
ExerciseDirect20K shares- - Jan 6, 2025ZYME
Zymeworks Inc.
SaleDirect11.1K shares at avg. $14.92$166K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 12, 2026 | ZYME Zymeworks Inc. | Exercise | 17,666 | - | $0 | Direct |
| Jan 12, 2026 | ZYME Zymeworks Inc. | Sale | 9,310 | $22.67 | $211,090 | Direct |
| Jan 5, 2026 | ZYME Zymeworks Inc. | Exercise | 20,000 | - | $0 | Direct |
| Jan 5, 2026 | ZYME Zymeworks Inc. | Sale | 10,538 | $25.10 | $264,471 | Direct |
| Jan 10, 2025 | ZYME Zymeworks Inc. | Award Restricted Stock Unit | 53,000 | - | - | Direct |
| Jan 10, 2025 | ZYME Zymeworks Inc. | Award Stock Option (Right to Buy) | 79,000 | - | - | Direct |
| Jan 6, 2025 | ZYME Zymeworks Inc. | Exercise | 20,000 | - | $0 | Direct |
| Jan 6, 2025 | ZYME Zymeworks Inc. | Sale | 11,110 | $14.92 | $165,807 | Direct |
1-8 of 8 transactions